45 related articles for article (PubMed ID: 31614021)
1. Rationalization of the Superior Anticancer Activity of Phenanthriplatin: An In-Depth Computational Exploration.
Dabbish E; Russo N; Sicilia E
Chemistry; 2020 Jan; 26(1):259-268. PubMed ID: 31614021
[TBL] [Abstract][Full Text] [Related]
2. Anti-cancer characteristics and ototoxicity of platinum(II) amine complexes with only one leaving ligand.
Monroe JD; Hruska HL; Ruggles HK; Williams KM; Smith ME
PLoS One; 2018; 13(3):e0192505. PubMed ID: 29513752
[TBL] [Abstract][Full Text] [Related]
3. The chiral potential of phenanthriplatin and its influence on guanine binding.
Johnstone TC; Lippard SJ
J Am Chem Soc; 2014 Feb; 136(5):2126-34. PubMed ID: 24417436
[TBL] [Abstract][Full Text] [Related]
4. Nucleotide Binding Preference of the Monofunctional Platinum Anticancer-Agent Phenanthriplatin.
Riddell IA; Johnstone TC; Park GY; Lippard SJ
Chemistry; 2016 May; 22(22):7574-81. PubMed ID: 27111128
[TBL] [Abstract][Full Text] [Related]
5. Monofunctional and higher-valent platinum anticancer agents.
Johnstone TC; Wilson JJ; Lippard SJ
Inorg Chem; 2013 Nov; 52(21):12234-49. PubMed ID: 23738524
[TBL] [Abstract][Full Text] [Related]
6. Effects of monofunctional platinum agents on bacterial growth: a retrospective study.
Johnstone TC; Alexander SM; Lin W; Lippard SJ
J Am Chem Soc; 2014 Jan; 136(1):116-8. PubMed ID: 24364388
[TBL] [Abstract][Full Text] [Related]
7. Disturbance of DNA conformation by the binding of testosterone-based platinum drugs via groove-face and intercalative interactions: a molecular dynamics simulation study.
Cui S; Wang Y; Chen G
BMC Struct Biol; 2013 Mar; 13():4. PubMed ID: 23517640
[TBL] [Abstract][Full Text] [Related]
8. Speciation of Phenanthriplatin and Its Analogs in the Core of Tobacco Mosaic Virus.
Vernekar AA; Berger G; Czapar AE; Veliz FA; Wang DI; Steinmetz NF; Lippard SJ
J Am Chem Soc; 2018 Mar; 140(12):4279-4287. PubMed ID: 29553267
[TBL] [Abstract][Full Text] [Related]
9. Photoactive monofunctional platinum(II) anticancer complexes of multidentate phenanthridine-containing ligands: photocytotoxicity and evidence for interaction with DNA.
Lozada IB; Gussakovsky D; Jayawardhana AMDS; McKenna SA; Zheng YR; Herbert DE
Photochem Photobiol Sci; 2023 Nov; 22(11):2587-2597. PubMed ID: 37725299
[TBL] [Abstract][Full Text] [Related]
10. A monofunctional Pt(II) complex combats triple negative breast cancer by triggering lysosome-dependent cell death.
Shen X; Peng Y; Yang Z; Li R; Zhou H; Ye X; Han Z; Shi X
Dalton Trans; 2024 Feb; 53(8):3808-3817. PubMed ID: 38305380
[TBL] [Abstract][Full Text] [Related]
11. Expanding the palette of phenanthridinium cations.
Cairns AG; Senn HM; Murphy MP; Hartley RC
Chemistry; 2014 Mar; 20(13):3742-51. PubMed ID: 24677631
[TBL] [Abstract][Full Text] [Related]
12. Click-Capable Phenanthriplatin Derivatives as Tools to Study Pt(II)-Induced Nucleolar Stress.
O'Dowd PD; Guerrero AS; Alley KR; Pigg HC; O'Neill F; Meiller J; Hobbs C; Rodrigues DA; Twamley B; O'Sullivan F; DeRose VJ; Griffith DM
ACS Chem Biol; 2024 Apr; 19(4):875-885. PubMed ID: 38483263
[TBL] [Abstract][Full Text] [Related]
13. Wireframe DNA Origami for the Cellular Delivery of Platinum(II)-Based Drugs.
De Luca E; Wang Y; Baars I; De Castro F; Lolaico M; Migoni D; Ducani C; Benedetti M; Högberg B; Fanizzi FP
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069036
[TBL] [Abstract][Full Text] [Related]
14. Computational Assessment of a Dual-Action Ru(II)-Based Complex: Photosensitizer in Photodynamic Therapy and Intercalating Agent for Inducing DNA Damage.
Ponte F; Scoditti S; Barretta P; Mazzone G
Inorg Chem; 2023 Jun; 62(23):8948-8959. PubMed ID: 37248070
[TBL] [Abstract][Full Text] [Related]
15. Computational Analysis of the Behavior of BODIPY Decorated Monofunctional Platinum(II) Complexes in the Dark and under Light Irradiation.
Barretta P; Ponte F; Scoditti S; Vigna V; Mazzone G; Sicilia E
J Phys Chem A; 2022 Oct; 126(40):7159-7167. PubMed ID: 36194386
[TBL] [Abstract][Full Text] [Related]
16. Enantioselective Cytotoxicity of Chiral Diphosphine Ruthenium(II) Complexes Against Cancer Cells.
Lovison D; Alessi D; Allegri L; Baldan F; Ballico M; Damante G; Galasso M; Guardavaccaro D; Ruggieri S; Melchior A; Veclani D; Nardon C; Baratta W
Chemistry; 2022 Jun; 28(33):e202200200. PubMed ID: 35394095
[TBL] [Abstract][Full Text] [Related]
17. Square-Planar vs. Trigonal Bipyramidal Geometry in Pt(II) Complexes Containing Triazole-Based Glucose Ligands as Potential Anticancer Agents.
Annunziata A; Liberti D; Bedini E; Cucciolito ME; Loreto D; Monti DM; Merlino A; Ruffo F
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445409
[TBL] [Abstract][Full Text] [Related]
18. Intercalation Ability of Novel Monofunctional Platinum Anticancer Drugs: A Key Step in Their Biological Action.
Veclani D; Tolazzi M; Cerón-Carrasco JP; Melchior A
J Chem Inf Model; 2021 Sep; 61(9):4391-4399. PubMed ID: 34156233
[TBL] [Abstract][Full Text] [Related]
19. Theoretical Prediction of Dual-Potency Anti-Tumor Agents: Combination of Oxoplatin with Other FDA-Approved Oncology Drugs.
Cerón-Carrasco JP
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635199
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
